Latest in: diagnostics
Featured Image

Life science incentives; UAE vs Central Europe

UAE has become one of the leading Middle Eastern countries in the biotechnology and pharmaceutical industry due to its heavy investment and development in the sector. In particular, the Dubai Free Zones and the …
gravatar
 · 
March 16, 2023
Featured Image

NGS in clinical routine – where are we in 2022?

Next-generation sequencing (NGS)—a form of DNA sequencing that can examine millions of DNA molecules simultaneously—is proving to be crucial to the successful execution of the concept of precision medicine in oncology but its utility …
gravatar
 · 
October 10, 2022
Featured Image

Companion diagnostics – status in 2022 and future outlook

Companion diagnostics (CDx) is used as a companion to a therapeutic agent to determine its applicability (e.g. predict response to therapy, toxicity...) to a specific person. Commonly, companion diagnostics is named as one of …
gravatar
 · 
July 5, 2022
Featured Image

Diagnostics with strong presence in the top 10 healthcare trends by CADTH

Canadian Health Technology Assessment (HTA) agency CADTH has recently published a "Horizon Scan" naming health technology trends with expected large impact on Canada that have the potential to harness large volumes of data, improve …
gravatar
 · 
May 25, 2022
Featured Image

What impact did COVID-19 really have on the diagnostics market?

The black swan event nobody could have really predicted. 400 million cases around the world and great strain on healthcare systems, physical and mental capacities of people globally. Could there be a silver lining to the …
gravatar
 · 
May 2, 2022

Impressum

ambiom s.r.o.
Karpatské námestie 7770/10A
831 06 Bratislava
IČO: 54219035

Contact

info@ambiom.com
+421 948 652 276

footer-FB
footer-Li
Footer-Insta

Newsletter

Back to top Arrow